Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.N K Cheung, Nathan A. Berger, Hillard M. Lazarus et al.|Journal of Clinical Oncology|1987Cited by 415